Akebia Therapeutics (AKBA) Cash from Financing Activities (2013 - 2026)
Akebia Therapeutics (AKBA) recorded Cash from Financing Activities of -$6.54 million in Q2 2026, compared with $1.72 million a year earlier.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Cash from Financing Activities (2013 - 2026) Analysis & Trends
On a TTM basis, Akebia Therapeutics' Cash from Financing Activities came in at -$11.2 million as of Jun 30, 2026; for FY2025, it was $72.93 million, up 46.8% from FY2024.
- Annual Cash from Financing Activities has a five-year compound annual growth rate of -20.6% (FY2020 to FY2025).
- Across earlier years, Cash from Financing Activities came in at $49.66 million in FY2024, -$25.21 million in FY2023, $14.6 million in FY2022 (-89.1%) and $133.73 million in FY2021 (-42.3%).
- The Q2 2026 figure is the lowest quarterly Cash from Financing Activities since Q2 2023.
- Per Business Quant, the preceding three quarters came in at -$926,000 (Q1 2026), -$4.85 million (Q4 2025) and $1.11 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -7.22 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -8.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 6.82 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -2.43 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 6.63 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -4.39 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -1.53 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | -2.51 Bn |
| 10 | Akebia Therapeutics | 149.86 Mn | -512.48 Mn | 30.54 Mn | 3.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.18 Mn |
| Jun 30, 2026 | -6.54 Mn |
| Mar 31, 2026 | -926,000.00 |
| Dec 31, 2025 | -4.85 Mn |
| Sep 30, 2025 | 1.11 Mn |
| Jun 30, 2025 | 1.72 Mn |
| Mar 31, 2025 | 74.94 Mn |
| Dec 31, 2024 | 22.33 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 7.64 Mn |
| Mar 31, 2024 | 18.48 Mn |
| Dec 31, 2023 | -1.29 Mn |
| Sep 30, 2023 | 50,000.00 |
| Jun 30, 2023 | -8.00 Mn |
| Mar 31, 2023 | -15.97 Mn |
| Dec 31, 2022 | -1,000.00 |
| Sep 30, 2022 | -32.94 Mn |
| Jun 30, 2022 | -9,000.00 |
| Mar 31, 2022 | 47.55 Mn |
| Dec 31, 2021 | 5.40 Mn |
API Access
Akebia Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();